Ameritas Investment Partners’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.1K | Hold |
9,805
| – | – | ﹤0.01% | 2226 |
|
|
2026
Q1 | $22.4K | Hold |
9,805
| – | – | ﹤0.01% | 2544 |
|
|
2025
Q4 | $39.2K | Hold |
9,805
| – | – | ﹤0.01% | 2290 |
|
|
2025
Q3 | $83K | Sell |
9,805
-1,599
| -14% | -$15.5K | ﹤0.01% | 1799 |
|
|
2025
Q2 | $128K | Hold |
11,404
| – | – | ﹤0.01% | 1581 |
|
|
2025
Q1 | $108K | Hold |
11,404
| – | – | ﹤0.01% | 1652 |
|
|
2024
Q4 | $128K | Hold |
11,404
| – | – | ﹤0.01% | 1618 |
|
|
2024
Q3 | $323K | Hold |
11,404
| – | – | 0.01% | 1043 |
|
|
2024
Q2 | $218K | Hold |
11,404
| – | – | 0.01% | 1210 |
|
|
2024
Q1 | $374K | Hold |
11,404
| – | – | 0.01% | 926 |
|
|
2023
Q4 | $377K | Buy |
11,404
+458
| +4% | +$13K | 0.01% | 905 |
|
|
2023
Q3 | $298K | Buy |
10,946
+1,848
| +20% | +$51.4K | 0.01% | 959 |
|
|
2023
Q2 | $276K | Buy |
9,098
+2,670
| +42% | +$86.3K | 0.01% | 959 |
|
|
2023
Q1 | $209K | Hold |
6,428
| – | – | 0.01% | 1072 |
|
|
2022
Q4 | $204K | Hold |
6,428
| – | – | 0.01% | 1128 |
|
|
2022
Q3 | $230K | Buy |
6,428
+287
| +5% | +$10.1K | 0.01% | 995 |
|
|
2022
Q2 | $188K | Hold |
6,141
| – | – | 0.01% | 1101 |
|
|
2022
Q1 | $198K | Hold |
6,141
| – | – | 0.01% | 1191 |
|
|
2021
Q4 | $170K | Hold |
6,141
| – | – | 0.01% | 1327 |
|
|
2021
Q3 | $190K | Hold |
6,141
| – | – | 0.01% | 1238 |
|
|
2021
Q2 | $130K | Hold |
6,141
| – | – | ﹤0.01% | 1560 |
|
|
2021
Q1 | $124K | Sell |
6,141
-439
| -7% | -$8.35K | ﹤0.01% | 1529 |
|
|
2020
Q4 | $105K | Hold |
6,580
| – | – | ﹤0.01% | 1563 |
|
|
2020
Q3 | $82K | Hold |
6,580
| – | – | ﹤0.01% | 1554 |
|
|
2020
Q2 | $47K | Hold |
6,580
| – | – | ﹤0.01% | 1864 |
|
|
2020
Q1 | $36K | Buy |
6,580
+823
| +14% | +$7.35K | ﹤0.01% | 1844 |
|
|
2019
Q4 | $52K | Hold |
5,757
| – | – | ﹤0.01% | 1893 |
|
|
2019
Q3 | $41K | Hold |
5,757
| – | – | ﹤0.01% | 2000 |
|
|
2019
Q2 | $46K | Hold |
5,757
| – | – | ﹤0.01% | 1958 |
|
|
2019
Q1 | $72K | Hold |
5,757
| – | – | ﹤0.01% | 1680 |
|
|
2018
Q4 | $115K | Hold |
5,757
| – | – | 0.01% | 1284 |
|
|
2018
Q3 | $163K | Hold |
5,757
| – | – | 0.01% | 1228 |
|
|
2018
Q2 | $121K | Buy |
5,757
+657
| +13% | +$12.4K | 0.01% | 1408 |
|
|
2018
Q1 | $73K | Buy |
5,100
+613
| +14% | +$8.77K | ﹤0.01% | 1692 |
|
|
2017
Q4 | $55K | Buy |
4,487
+1,100
| +32% | +$15.5K | ﹤0.01% | 1878 |
|
|
2017
Q3 | $56K | Hold |
3,387
| – | – | ﹤0.01% | 1819 |
|
|
2017
Q2 | $86K | Buy |
3,387
+2,037
| +151% | +$49K | ﹤0.01% | 1555 |
|
|
2017
Q1 | $30K | Buy |
+1,350
| New | +$25.9K | ﹤0.01% | 2161 |
|
Other funds holding EVH
CCM
RF
EC
Ameritas Investment Partners's EVH Position: Q2 2026 in Review
Ameritas Investment Partners held its Evolent Health (EVH) position steady in Q2 2026 at 9,805 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.
Ameritas Investment Partners first reported a position in EVH in Q1 2017 and has held it in 38 quarters since. The position peaked at $377K in Q4 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.
- Ameritas Investment Partners held 9,805 shares of Evolent Health worth $53.1K as of Q2 2026.
- Ameritas Investment Partners left its Evolent Health share count unchanged in Q2 2026.
- Evolent Health made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2226 holding.
- Ameritas Investment Partners first reported a position in Evolent Health in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's Evolent Health position peaked at $377K in Q4 2023.
- 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.